{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:46Z","timestamp":1761581326064,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.urolonc.2015.05.032","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T21:41:15Z","timestamp":1436305275000},"page":"424.e17-424.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy"],"prefix":"10.1016","volume":"33","author":[{"given":"Stefano","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Passera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Bollito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Cappia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mario Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Franco Randone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.05.032_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: the evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","article-title":"Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer","volume":"55","author":"Okada","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1464-410X.2007.07267.x","article-title":"Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after four years?","volume":"101","author":"Wolters","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.05.032_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1742-1241.2006.00905.x","article-title":"Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy","volume":"61","author":"Karakiewicz","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.urolonc.2015.05.032_bib6","first-page":"7159","article-title":"Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy","volume":"34","author":"De Luca","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2015.05.032_bib7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.juro.2006.04.033","article-title":"The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study","volume":"176","author":"MacLennan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.urology.2008.07.028","article-title":"Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50ng\/ml","volume":"72","author":"Terakawa","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib9","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.juro.2009.07.093","article-title":"Prostate-specific antigen best practice statement: 2009 update","volume":"182","author":"Greene","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/0019-509X.146790","article-title":"Low free to total PSA ratio is not a good discriminator of chronic prostatitis and prostate cancer: an Indian experience","volume":"51","author":"Thakur","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.urolonc.2015.05.032_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3 (PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"Aptima PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.urolonc.2015.05.032_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pros.21457","article-title":"Chronic prostatitis does not influence urinary PCA3 score","volume":"72","author":"Vlaeminck-Guillem","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2015.05.032_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.urology.2013.10.016","article-title":"Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in men with a total prostate-specific antigen of 4-10 ng\/ml and normal digital rectal examination","volume":"83","author":"Lazzeri","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.urology.2009.05.100","article-title":"Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen","volume":"76","author":"Joseph","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib17","unstructured":"Agenzia Italiana del Farmaco. Linee guida per la classificazione e la conduzione degli studi osservazionali sui farmaci. Roma 20.03.2008"},{"key":"10.1016\/j.urolonc.2015.05.032_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/pros.2990200205","article-title":"Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate","volume":"20","author":"Neal","year":"1992","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2015.05.032_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.urology.2011.02.061","article-title":"Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center","volume":"78","author":"Lin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.032_bib20","first-page":"3","article-title":"Infections and inflammation in prostate cancer","volume":"1","author":"Sfanos","year":"2013","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.juro.2010.12.058","article-title":"Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy","volume":"185","author":"Fujita","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.05.032_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.juro.2008.01.034","article-title":"Evaluation of prostatitis in autopsied prostates\u2014is chronic inflammation more associated with benign prostatic hyperplasia or cancer?","volume":"179","author":"Delongchamps","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2015.05.032_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.urolonc.2015.05.032_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncpuro0702","article-title":"The responsible use of antibiotics for an elevated PSA level","volume":"4","author":"Scardino","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","article-title":"Ratio of free to total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate","volume":"159","author":"Jung","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.eururo.2010.06.038","article-title":"External validation of urinary PCA3\u2013based nomograms to individually predict prostate biopsy outcome","volume":"58","author":"Auprich","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10ng\/ml: a multicentric European study","volume":"63","author":"Lazzeri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.032_bib31","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1111\/j.1464-410X.2012.11645.x","article-title":"Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score","volume":"110","author":"De Luca","year":"2012","journal-title":"BJU Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915002781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915002781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:05:47Z","timestamp":1761041147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915002781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1078143915002781"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.032","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}